Chelsea Technologies Group aids fight for bio-security
Chelsea Technologies Group has designed an ‘on-site rapid diagnostics screening system’ to detect & identify micro-organisms following a terrorist attack. Over recent years Chelsea Technologies Group has developed a novel, low-cost, optical system for reading low-density protein microarrays, work done in partnership with Microtest Matrices Ltd (a spin out from Imperial College, London). With additional government sponsorship under the Home Office’s CBRN programme, this advance has enabled us in partnership with MtM and The Health Inspection Agency to develop a fully automated portable microarray processing platform for on-site diagnosis, a step which had hitherto been inhibited by the sophistication and expense of the optical imaging techniques available for reading high density DNA arrays, which until now has been the main driver for the development of this format.
On-Site Rapid Diagnostic Screening System
The portable platform is designed to be rapidly deployed in the event of unexplained clusters of acute illness or fatality, to screen for the presence of a comprehensive panel of micro-organisms that might be associated with a deliberate terrorist attack, allowing these to be ruled out as a potential threat early in any investigation. The microarray format that the team has developed can readily be adapted for other applications, including the detection of potentially harmful chemicals in water supplies or for multi-analyte detection in the medical diagnostics market.
Chelsea Technologies is keen to meet with organizations interested in collaborating on commercialization of this platform. Please contact Ellen Keegan for more information or to set up a meeting.